Model
Edge
Acrivon Therapeutics Inc.
0001841088
Filing type
4
Filing date
May 19, 2026
Updated
May 20, 2026 ยท 2:30 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership